According to the new market research report “Non-Invasive PrenatalNon-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690
Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.
Global Non Invasive Prenatal Testing (NIPT) Market Segmentation:
By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.
Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type). In 2018, trisomy was the largest application segment of the NIPT market. This segment is also estimated to grow at the highest CAGR during the forecast period.
Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690
What Drives the Market?
1. High Risk of Chromosomal Abnormalities With Increasing Maternal Age
2. Growing Preference for Noninvasive Techniques Over Invasive Methods
3. Improving Reimbursement Scenario for NIPT
4. Programs Focusing on Increasing the Awareness of NIPT
Geographical Growth Analysis:
Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region
Key Players and Strategies Adopted by Them:
The NIPT market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=145607690
Non Invasive Prenatal Testing (NIPT) Market : Future of Healthcare, it is Creating Real Change in the Healthcare Industry
Small DNA fragments in the mother's blood are used to identify particular genetic material (genetic material that defines the makeup of the human cell and protein building blocks).
Every mother's blood contains these tiny particles.Non-invasive prenatal testing (NIPT) exams have produced sufficient data to demonstrate their effectiveness.
The technique has been shown to be both effective and safe for the unborn child, and it has also been shown to help reduce the chances of premature birth and fetal abnormalities.
Certain institutions, however, continue to follow strict rules, as certain research show that NIPT testing might result in false positive findings.
When the mother's blood samples are examined during in vitro fertilization, non-invasive prenatal testing (NIPT) is used to determine the fetus' DNA or genetic make-up using non-invasive techniques.
If they're the same, the infant is considered normal.
Non-invasive prenatal testing is gradually being accepted by pregnant women with high-risk for screening common fetal chromosomal aneuploidies such as Edward’s syndrome (trisomy 18), Down syndrome (trisomy 21), Turner syndrome (monosomy X) and Patau syndrome (trisomy 13).
Accuracy, safety, and non-invasiveness are the key factors credited to the acceptance of these tests amongst gynecologists and expecting mothers related to invasive tests such as amniocentesis and chorionic villus sampling (CVS).
However, BGI’s NIFTY is likely to overtake MaterniT21 PLUS in terms of volume in the global market.
Read Report Overview - https://www.transparencymarketresearch.com/next-generation-sequencing-for-non-invasive-prenatal-testing-market.html Next generation sequencing is used in the sequencing technologies that immensely parallelize the DNA sequencing process rather than limited few fragments or to a single of DNA.
These rare diseases are mostly caused by changes in genes, which is presently lack of effective treatment.
Hence, developing an effective method to perform noninvasive prenatal test (NIPT) for rare diseases is the crucial challenge to inhibit birth defect in the future.Request COVID Analysis on Next-Generation Sequencing for Non-Invasive Prenatal Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=14135 The exponential progress of the NIPT market is supported by factors such as no risk of miscarriage with NIPT, high incidence rate of babies born with Down syndrome, and shifting trend toward child bearing at advanced maternal age.
Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690Growth prospects in Non Invasive Prenatal Testing (NIPT) Market :The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.
However, a dearth of skilled professionals is restraining the growth of this market.By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
In 2018, trisomy was the largest application segment of the NIPT market.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.
In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.Inquire or share your questions if any before the purchasing this report: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.Key Factors Driving Market Growth:Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Revenue Growth Analysis:The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.Accessories to Fuel the Growth of Non Invasive Prenatal Testing (NIPT) Market:By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.
The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.Browse in-depth TOC on “Non Invasive Prenatal Testing (NIPT) Market”112 – Tables31 – Figures144 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.
Europe Non–Invasive Prenatal Testing Market study by “KD Market Insights” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.An exclusive Europe Non–Invasive Prenatal Testing market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.
The segmentation of the market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases).
Further, the market has been estimated by utilizing various research methodologies and internal statistical model.Europe Non–Invasive Prenatal Testing market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Europe Non–Invasive Prenatal Testing market to offer worthwhile insights and current scenario for making right decision.
The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years.
Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the global industry player and helps the companies to garner Europe Non–Invasive Prenatal Testing market revenue by understanding the strategic growth approaches.
This report provides qualified research on the market to evaluate the key players by calibrating all the relevant products/services to understand the positioning of the major players in Europe Non–Invasive Prenatal Testing market.The report is a combination of qualitative and quantitative analysis of the virtual reality industry.
Global Non-Invasive Prenatal Testing (NIPT) Market Research Report: By Product Type (Devices, Consumables, Others), By Techniques (Biochemical Screening Tests, Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, Others) and By End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) – Forecast to 2025Market Highlights:According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition.
As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.
The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.However, less accuracy of non-invasive prenatal testing compared to invasive prenatal testing is likely to hamper the growth of the global NIPT market during the forecast period.Several market players currently dominate the global NIPT market.
The key players are involved in product launches and strategic collaborations to strengthen their market positions.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8371 Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures.
The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.
The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.Key Factors Driving Market Growth:Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.Revenue Growth Analysis:The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.Accessories to Fuel the Growth of Non Invasive Prenatal Testing (NIPT) Market:By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.
The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.Browse in-depth TOC on “Non Invasive Prenatal Testing (NIPT) Market”112 – Tables31 – Figures144 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
The large share and high growth of this segment can primarily be attributed to factors such as the increasing maternal age and the rising incidence of chromosomal abnormalities.The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.
Small DNA fragments in the mother's blood are used to identify particular genetic material (genetic material that defines the makeup of the human cell and protein building blocks).
Every mother's blood contains these tiny particles.Non-invasive prenatal testing (NIPT) exams have produced sufficient data to demonstrate their effectiveness.
The technique has been shown to be both effective and safe for the unborn child, and it has also been shown to help reduce the chances of premature birth and fetal abnormalities.
Certain institutions, however, continue to follow strict rules, as certain research show that NIPT testing might result in false positive findings.
When the mother's blood samples are examined during in vitro fertilization, non-invasive prenatal testing (NIPT) is used to determine the fetus' DNA or genetic make-up using non-invasive techniques.
If they're the same, the infant is considered normal.
Non-invasive prenatal testing is gradually being accepted by pregnant women with high-risk for screening common fetal chromosomal aneuploidies such as Edward’s syndrome (trisomy 18), Down syndrome (trisomy 21), Turner syndrome (monosomy X) and Patau syndrome (trisomy 13).
Accuracy, safety, and non-invasiveness are the key factors credited to the acceptance of these tests amongst gynecologists and expecting mothers related to invasive tests such as amniocentesis and chorionic villus sampling (CVS).
However, BGI’s NIFTY is likely to overtake MaterniT21 PLUS in terms of volume in the global market.
Read Report Overview - https://www.transparencymarketresearch.com/next-generation-sequencing-for-non-invasive-prenatal-testing-market.html Next generation sequencing is used in the sequencing technologies that immensely parallelize the DNA sequencing process rather than limited few fragments or to a single of DNA.
These rare diseases are mostly caused by changes in genes, which is presently lack of effective treatment.
Hence, developing an effective method to perform noninvasive prenatal test (NIPT) for rare diseases is the crucial challenge to inhibit birth defect in the future.Request COVID Analysis on Next-Generation Sequencing for Non-Invasive Prenatal Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=14135 The exponential progress of the NIPT market is supported by factors such as no risk of miscarriage with NIPT, high incidence rate of babies born with Down syndrome, and shifting trend toward child bearing at advanced maternal age.
Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.According to the new market research report “Non-Invasive Prenatal Testing Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690Growth prospects in Non Invasive Prenatal Testing (NIPT) Market :The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.
However, a dearth of skilled professionals is restraining the growth of this market.By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
In 2018, trisomy was the largest application segment of the NIPT market.Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.
In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.Inquire or share your questions if any before the purchasing this report: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=145607690Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
Europe Non–Invasive Prenatal Testing Market study by “KD Market Insights” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.An exclusive Europe Non–Invasive Prenatal Testing market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.
The segmentation of the market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases).
Further, the market has been estimated by utilizing various research methodologies and internal statistical model.Europe Non–Invasive Prenatal Testing market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Europe Non–Invasive Prenatal Testing market to offer worthwhile insights and current scenario for making right decision.
The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years.
Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the global industry player and helps the companies to garner Europe Non–Invasive Prenatal Testing market revenue by understanding the strategic growth approaches.
This report provides qualified research on the market to evaluate the key players by calibrating all the relevant products/services to understand the positioning of the major players in Europe Non–Invasive Prenatal Testing market.The report is a combination of qualitative and quantitative analysis of the virtual reality industry.
Global Non-Invasive Prenatal Testing (NIPT) Market Research Report: By Product Type (Devices, Consumables, Others), By Techniques (Biochemical Screening Tests, Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, Others) and By End-User (Diagnostic Laboratories, Hospitals, cell DNA screening) – Forecast to 2025Market Highlights:According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition.
As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.
The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.However, less accuracy of non-invasive prenatal testing compared to invasive prenatal testing is likely to hamper the growth of the global NIPT market during the forecast period.Several market players currently dominate the global NIPT market.
The key players are involved in product launches and strategic collaborations to strengthen their market positions.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8371 Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures.
The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.